FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41075911000001100: Oxbryta 500mg tablets (Pfizer Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Oct 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2910181000001117 Oxbryta 500mg tablets (Pfizer Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2910191000001115 Oxbryta 500mg tablets (Pfizer Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxbryta 500mg tablets (Pfizer Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction restricted availability true Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) Is a Voxelotor 500mg tablets true Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) Is a Oxbryta true Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) Has specific active ingredient Voxelotor false Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxbryta 500mg tablets (Pfizer Ltd) Has specific active ingredient Voxelotor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Oxbryta 500mg tablets (Pfizer Ltd) 90 tablet Has AMP True Oxbryta 500mg tablets (Pfizer Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start